MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$9,167K
Free Cash flow
-$9,440K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Accrued expenses and other curre...
    • Inventory
    • Stock-based compensation expense
    • Others
Negative Cash Flow Breakdown
    • Accounts payable
    • Prepaid expenses and other curre...
    • Purchase of property and equipme...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-11,262
-12,273
-9,041
-8,603
Depreciation expense
171
169
130
153
Noncash interest expense
240
238
159
110
Noncash loss on extinguishment of debt
-
-
888
-
Amortization of intangible assets
95
95
95
95
Net changes in operating lease rou assets and liabilities
22
21
21
-375
Inventory excess and obsolescence charge
298
935
818
632
Stock-based compensation expense
613
816
812
955
Income tax expense
60
60
230
-
Deferred income tax expense
-
-
-
0
Loss on disposal of fixed assets
0
-18
-
-
Accounts receivable, net
-89
-593
-932
107
Inventory
-862
2,158
275
838
Prepaid expenses and other current and long-term assets
838
-231
153
-272
Accounts payable
-1,014
1,593
-63
652
Accrued expenses and other current and long-term liabilities
1,318
-1,498
663
633
Foreign currency transaction loss
-9
-32
-41
48
Net cash used in operating activities
-9,381
-11,170
-4,870
-5,719
Purchase of property and equipment
59
119
91
211
Proceeds from the sale of product line
298
309
283
523
Net cash provided by investing activities
239
190
192
312
Proceeds from sale of common stock and pre-funded warrants, net
-
-
11,823
-
Proceeds from issuance of long-term debt and warrants
-
-
60,000
-
Repayment of long-term debt
-
-
42,420
-
Payment of debt financing costs
-
-
3,554
-
Payment of accrued offering costs
0
247
-
-
Proceeds from exercise of stock options
-
-
0
0
Vesting of restricted stock units
0
1
-
-
Payment of withholding taxes related to stock-based compensation to employees
15
79
4
21
Proceeds from issuance of common stock under the employee stock purchase plan
0
27
0
45
Net cash used in financing activities
-15
-298
25,845
24
Effect of exchange rate on cash and cash equivalents
-10
-26
-35
104
Net decrease in cash and cash equivalents and restricted cash
-9,167
-11,304
21,132
-5,279
Cash and cash equivalents and restricted cash, beginning of period
39,791
51,095
29,963
52,935
Cash and cash equivalents and restricted cash, end of period
30,624
39,791
51,095
29,963
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from the sale ofproduct line$298K (-38.93%↓ Y/Y)Net cash provided byinvesting activities$239K (-30.12%↓ Y/Y)Canceled cashflow$59K Net decrease in cashand cash...-$9,167K (48.19%↑ Y/Y)Canceled cashflow$239K Accrued expenses andother current and...$1,318K (184.05%↑ Y/Y)Inventory-$862K (-41.31%↓ Y/Y)Stock-based compensationexpense$613K (-69.79%↓ Y/Y)Inventory excess andobsolescence charge$298K (-67.25%↓ Y/Y)Noncash interestexpense$240K (-7.69%↓ Y/Y)Depreciation expense$171K (-50.72%↓ Y/Y)Amortization of intangibleassets$95K (-50.00%↓ Y/Y)Accounts receivable, net-$89K (-109.52%↓ Y/Y)Income tax expense$60K Foreign currencytransaction loss-$9K (89.16%↑ Y/Y)Purchase of property andequipment$59K (-59.59%↓ Y/Y)Net cash used inoperating activities-$9,381K (46.79%↑ Y/Y)Canceled cashflow$3,755K Net cash used infinancing activities-$15K (87.39%↑ Y/Y)Effect of exchange rateon cash and cash...-$10K (96.50%↑ Y/Y)Net loss-$11,262K (46.84%↑ Y/Y)Accounts payable-$1,014K (-126.34%↓ Y/Y)Prepaid expenses andother current and...$838K (6085.71%↑ Y/Y)Net changes inoperating lease rou assets...$22K (-57.69%↓ Y/Y)Payment of withholdingtaxes related to...$15K (-91.67%↓ Y/Y)

TELA Bio, Inc. (TELA)

TELA Bio, Inc. (TELA)